Details for Patent: 8,680,136
Which drugs does patent 8,680,136 protect, and when does it expire?
Patent 8,680,136 protects VABOMERE and is included in one NDA.
This patent has sixty-two patent family members in thirty countries.
Summary for Patent: 8,680,136
| Title: | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| Abstract: | Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to 1 cyclic boronic acid ester derivatives and their use as therapeutic agents. |
| Inventor(s): | Gavin Hirst, Raja Reddy, Scott Hecker, Maxim Totrov, David C. Griffith, Olga Rodny, Michael N. Dudley, Serge Boyer |
| Assignee: | Melinta Subsidiary Corp |
| Application Number: | US13/205,112 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,680,136
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | 8,680,136 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,680,136
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2603514 | ⤷ Start Trial | 300977 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2603514 | ⤷ Start Trial | 300978 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2603514 | ⤷ Start Trial | 122019000027 | Germany | ⤷ Start Trial |
| European Patent Office | 2603514 | ⤷ Start Trial | CA 2019 00015 | Denmark | ⤷ Start Trial |
| European Patent Office | 2603514 | ⤷ Start Trial | CA 2019 00016 | Denmark | ⤷ Start Trial |
| European Patent Office | 2603514 | ⤷ Start Trial | 2019C/515 | Belgium | ⤷ Start Trial |
| European Patent Office | 2603514 | ⤷ Start Trial | 2019C/514 | Belgium | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
